SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-088640
Filing Date
2022-03-30
Accepted
2022-03-30 07:37:53
Documents
2
Group Members
JONATHAN FLINTPOLARIS HEALTHCARE TECHNOLOGY OPPORTUNITIES FUND GP, L.L.C.POLARIS HEALTHCARE TECHNOLOGY OPPORTUNITIES FUND, L.P.POLARIS PARTNERS GP IX, L.L.C.POLARIS PARTNERS IX, L.P.POLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d224907dsc13da.htm SC 13D/A 209090
2 EX-99.6 d224907dex996.htm EX-99.6 2659
  Complete submission text file 0001193125-22-088640.txt   213857
Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92804 | Film No.: 22783159
SIC: 2836 Biological Products, (No Diagnostic Substances)